The small molecule inhibitor, SGX523, potently inhibits MET activation and MET-dependent signaling in glioma cells and inhibits proliferation, cell cycle progression, migration, invasion, and in vivo tumor growth [89]. The gene discussed is MET; the disease is central nervous system cancer.